Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-22T15:28:12.449Z Has data issue: false hasContentIssue false
  • English
  • Français

Recurrent Sinus Arrest in Association with Neuroleptic Malignant Syndrome

Published online by Cambridge University Press:  02 January 2018

A. K. Parry ,
L. P. Ormerod ,
G. W. Hamlin  and
P. T. Saleem
A. K. Parry
Affiliation:
Psychiatry, Queen's Park Hospital, Blackburn
L. P. Ormerod
Affiliation:
Queen's Park Hospital, Blackburn
G. W. Hamlin
Affiliation:
Blackburn Royal Infirmary, Blackburn
P. T. Saleem*
Affiliation:
Queen's Park Hospital, Blackburn
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

We report a case of neuroleptic malignant syndrome where the catatonia clearly followed the administration of neuroleptics and where the neurovegetative disturbance was remarkably severe, including episodes of tracheal spasm, apnoea and episodes of bradycardia, and sinus arrest requiring insertion of a temporary external pacing wire. To our knowledge, such severe disturbance has not previously been reported.

Type
Short Papers
Information
The British Journal of Psychiatry , Volume 164 , Issue 5 , May 1994 , pp. 689 - 691
Copyright
Copyright © 1994 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arya, D. K. (1992) Neuroleptic malignant syndrome and catatonia – other diagnostic considerations. Journal of the Royal Society of Medicine, 85, 60–61.Google Scholar
Castillo, E., Rubin, R. T. & Holsboer-Trachsler, E. (1989) Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 324–328.Google ScholarPubMed
Fleischacher, W. W., Unterweger, B., Kane, J. M., et al (1990) The neuroleptic malignant syndrome and its differentiation from lethal catatonia. Acta Psychiatrica Scandinavica, 81, 3–5.CrossRefGoogle Scholar
Hurst, J. W. (1986) The Heart (6th edn) p. 436. New York: McGraw-Hill.Google Scholar
Kellam, A. M. P. (1987) The neuroleptic malignant syndrome, so called. A survey of the world literature. British Journal of Psychiatry, 150, 752–759.CrossRefGoogle ScholarPubMed
Otani, K., Kaneko, S. & Fukushima, Y. (1992) Lethal catatonia and neuroleptic malignant syndrome. British Journal of Psychiatry (correspondence), 160, 424.CrossRefGoogle Scholar
Rosebush, P. I., Stewart, T. & Mazurek, M. F. (1991) The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care? British Journal of Psychiatry, 159, 709–712.CrossRefGoogle ScholarPubMed
Weller, M. (1992) Neuroleptic malignant syndrome and lethal catatonia. Journal of Clinical Psychiatry (correspondence), 53, 294–295.Google ScholarPubMed
White, D. A. C. (1992) Catatonia and the neuroleptic malignant syndrome – a single entity? British Journal of Psychiatry, 161, 558–560.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.